MedTrace Logo

Pharmacokinetics of Vancomycin in Adults Receiving ECMO

NCT00281281 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-12-06

No results posted yet for this study

Summary

1. Vancomycin is a drug that requires precise dosing and close monitoring to avoid drug toxicity.
2. There is limited data on the change of vancomycin pharmacokinetics in patients who need extracorporeal membrane oxygenation (ECMO).
3. This control trial is to understand:

1. whether the pharmacokinetics of vancomycin is influenced by the use ECMO
2. design the most appropriate dose of vancomycin in adult patients using ECMO.

Conditions

  • Extracorporeal Membrane Oxygenation

Interventions

DRUG

vancomycin

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Fe-Lin L Wu, MSCP, PhD · National Taiwan University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2007-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00281281 on ClinicalTrials.gov